Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

PURPOSE: A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma. PATIENTS AND METHODS: Patients received induct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Morris, Patrick G., Correa, Denise D., Yahalom, Joachim, Raizer, Jeffrey J., Schiff, David, Grant, Barbara, Grimm, Sean, Lai, Rose K., Reiner, Anne S., Panageas, Kathy, Karimi, Sasan, Curry, Richard, Shah, Gaurav, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5569679/
https://ncbi.nlm.nih.gov/pubmed/24101038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.50.4910
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados